DHA sbir phase II medical r & d contract for development of a chemical sterilant for use in austere environments, proposal no. - H2-0729
Ended Definitive Contract Awarded Last action
- Contract number
- HT942523C0009
- Awardee
-
TDA Research, Inc. UEI MK5ANJVWVZK7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,099,999
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $1,099,998.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Denver, CO 80033, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,099,999 |
About this award
TDA Research, Inc., a small business specializing in advanced materials science and medical device development, was awarded a $1.1 million Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Phase II contract for the development of a chemical sterilant suitable for use in austere environments. The contract, designated as a total small business set-aside and awarded on March 8, 2023, carries an ultimate completion date of July 7, 2025. The work will be performed at TDA Research's facility in Wheat Ridge, Colorado. Under the firm fixed-price contract structure, the company will advance its chemical sterilization technology from Phase I research to Phase II development, extending its demonstrated capabilities in delivering medical and defense-focused solutions to government agencies.
This award reflects TDA Research's established track record with the Defense Health Agency and broader Department of Defense components, having previously developed portable oxygen generators for casualty care and other critical medical technologies through SBIR vehicles. The DHA's investment in austere environment sterilization technology addresses a significant operational requirement for military medical personnel deployed in resource-limited settings. The Phase II contract enables the company to mature the technology toward practical military deployment while leveraging its extensive experience in federal research and development spanning materials innovation, engineering solutions, and device commercialization across multiple defense and civilian agencies.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Prospect Life Sciences, Inc. | $129,496 |
Quick answers
Who was awarded contract HT942523C0009?
HT942523C0009 was awarded to TDA Research, Inc. by Defense Health Agency (Department of Defense) on March 8, 2023.
How much is contract HT942523C0009 worth?
The government has obligated $1,099,999 on HT942523C0009.
Which agency awarded contract HT942523C0009?
Defense Health Agency (Department of Defense) awarded HT942523C0009, with funding from Medical Command (Department of the Army).
Was contract HT942523C0009 competed?
The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award